Local Drug Delivery Strategies for Glioblastoma Treatment
Glioblastoma multiforme (GBM) is a brain tumor notorious for its malignancy. The key reason for the limited efficacy of standard treatment is the high recurrence rate of GBM, even after surgical resection. Hence, intensive postsurgical chemical therapies, such as the systemic delivery of various dru...
Saved in:
| Published in | Brain tumor research and treatment Vol. 10; no. 3; pp. 151 - 157 |
|---|---|
| Main Authors | , , , |
| Format | Journal Article |
| Language | English |
| Published |
The Korean Brain Tumor Society; The Korean Society for Neuro-Oncology; The Korean Society for Pediatric Neuro-Oncology
01.07.2022
대한뇌종양학회 |
| Subjects | |
| Online Access | Get full text |
| ISSN | 2288-2405 2288-2413 2288-2413 |
| DOI | 10.14791/btrt.2022.0017 |
Cover
| Abstract | Glioblastoma multiforme (GBM) is a brain tumor notorious for its malignancy. The key reason for the limited efficacy of standard treatment is the high recurrence rate of GBM, even after surgical resection. Hence, intensive postsurgical chemical therapies, such as the systemic delivery of various drugs and/or drug combinations, are typically followed after surgery. However, overcoming the blood-brain barrier by systemic administration to efficiently deliver drugs to the brain tumor remains a daunting goal. Therefore, various local drug delivery methods showing potential for improved therapeutic efficacy have been proposed. In particular, the recent application of electronic devices for the controlled delivery of chemotherapy drugs to GBM tissue has attracted attention. We herein review the recent progress of local drug delivery strategies, including electronics-assisted strategies, at the research and commercial level. We also present a brief discussion of the unsolved challenges and future research direction of localized chemotherapy methods for GBM.Glioblastoma multiforme (GBM) is a brain tumor notorious for its malignancy. The key reason for the limited efficacy of standard treatment is the high recurrence rate of GBM, even after surgical resection. Hence, intensive postsurgical chemical therapies, such as the systemic delivery of various drugs and/or drug combinations, are typically followed after surgery. However, overcoming the blood-brain barrier by systemic administration to efficiently deliver drugs to the brain tumor remains a daunting goal. Therefore, various local drug delivery methods showing potential for improved therapeutic efficacy have been proposed. In particular, the recent application of electronic devices for the controlled delivery of chemotherapy drugs to GBM tissue has attracted attention. We herein review the recent progress of local drug delivery strategies, including electronics-assisted strategies, at the research and commercial level. We also present a brief discussion of the unsolved challenges and future research direction of localized chemotherapy methods for GBM. |
|---|---|
| AbstractList | Glioblastoma multiforme (GBM) is a brain tumor notorious for its malignancy. The key reason for the limited efficacy of standard treatment is the high recurrence rate of GBM, even after surgical resection. Hence, intensive postsurgical chemical therapies, such as the systemic delivery of various drugs and/or drug combinations, are typically followed after surgery. However, overcoming the blood-brain barrier by systemic administration to efficiently deliver drugs to the brain tumor remains a daunting goal. Therefore, various local drug delivery methods showing potential for improved therapeutic efficacy have been proposed. In particular, the recent application of electronic devices for the controlled delivery of chemotherapy drugs to GBM tissue has attracted attention. We herein review the recent progress of local drug delivery strategies, including electronics-assisted strategies, at the research and commercial level. We also present a brief discussion of the unsolved challenges and future research direction of localized chemotherapy methods for GBM.Glioblastoma multiforme (GBM) is a brain tumor notorious for its malignancy. The key reason for the limited efficacy of standard treatment is the high recurrence rate of GBM, even after surgical resection. Hence, intensive postsurgical chemical therapies, such as the systemic delivery of various drugs and/or drug combinations, are typically followed after surgery. However, overcoming the blood-brain barrier by systemic administration to efficiently deliver drugs to the brain tumor remains a daunting goal. Therefore, various local drug delivery methods showing potential for improved therapeutic efficacy have been proposed. In particular, the recent application of electronic devices for the controlled delivery of chemotherapy drugs to GBM tissue has attracted attention. We herein review the recent progress of local drug delivery strategies, including electronics-assisted strategies, at the research and commercial level. We also present a brief discussion of the unsolved challenges and future research direction of localized chemotherapy methods for GBM. Glioblastoma multiforme (GBM) is a brain tumor notorious for its malignancy. The key reason for the limited efficacy of standard treatment is the high recurrence rate of GBM, even after surgical resection. Hence, intensive postsurgical chemical therapies, such as the systemic delivery of various drugs and/or drug combinations, are typically followed after surgery. However, overcoming the blood-brain barrier by systemic administration to efficiently deliver drugs to the brain tumor remains a daunting goal. Therefore, various local drug delivery methods showing potential for improved therapeutic efficacy have been proposed. In particular, the recent application of electronic devices for the controlled delivery of chemotherapy drugs to GBM tissue has attracted attention. We herein review the recent progress of local drug delivery strategies, including electronics-assisted strategies, at the research and commercial level. We also present a brief discussion of the unsolved challenges and future research direction of localized chemotherapy methods for GBM. Glioblastoma multiforme (GBM) is a brain tumor notorious for its malignancy. The key reason for the lim- ited efficacy of standard treatment is the high recurrence rate of GBM, even after surgical resection. Hence, intensive postsurgical chemical therapies, such as the systemic delivery of various drugs and/ or drug combinations, are typically followed after surgery. However, overcoming the blood-brain barrier by systemic administration to efficiently deliver drugs to the brain tumor remains a daunting goal. There- fore, various local drug delivery methods showing potential for improved therapeutic efficacy have been proposed. In particular, the recent application of electronic devices for the controlled delivery of che- motherapy drugs to GBM tissue has attracted attention. We herein review the recent progress of local drug delivery strategies, including electronics-assisted strategies, at the research and commercial level. We also present a brief discussion of the unsolved challenges and future research direction of localized chemotherapy methods for GBM. KCI Citation Count: 0 |
| Author | Choi, Seung Hong Kim, Dae-Hyeong Jung, Sonwoo Cha, Gi Doo |
| AuthorAffiliation | 1 Center for Nanoparticle Research, Institute for Basic Science (IBS), Seoul, Korea 4 Department of Materials Science and Engineering, College of Engineering, Seoul National University, Seoul, Korea 2 School of Chemical and Biological Engineering, Institute of Chemical Processes, Seoul National University, Seoul, Korea 3 Department of Radiology, Seoul National University College of Medicine, Seoul, Korea |
| AuthorAffiliation_xml | – name: 2 School of Chemical and Biological Engineering, Institute of Chemical Processes, Seoul National University, Seoul, Korea – name: 3 Department of Radiology, Seoul National University College of Medicine, Seoul, Korea – name: 1 Center for Nanoparticle Research, Institute for Basic Science (IBS), Seoul, Korea – name: 4 Department of Materials Science and Engineering, College of Engineering, Seoul National University, Seoul, Korea |
| Author_xml | – sequence: 1 givenname: Gi Doo orcidid: 0000-0002-4771-3396 surname: Cha fullname: Cha, Gi Doo organization: Center for Nanoparticle Research, Institute for Basic Science (IBS), Seoul, Korea., School of Chemical and Biological Engineering, Institute of Chemical Processes, Seoul National University, Seoul, Korea., Department of Radiology, Seoul National University College of Medicine, Seoul, Korea – sequence: 2 givenname: Sonwoo orcidid: 0000-0002-3797-8024 surname: Jung fullname: Jung, Sonwoo organization: Center for Nanoparticle Research, Institute for Basic Science (IBS), Seoul, Korea., School of Chemical and Biological Engineering, Institute of Chemical Processes, Seoul National University, Seoul, Korea – sequence: 3 givenname: Seung Hong orcidid: 0000-0002-0412-2270 surname: Choi fullname: Choi, Seung Hong organization: Center for Nanoparticle Research, Institute for Basic Science (IBS), Seoul, Korea., Department of Radiology, Seoul National University College of Medicine, Seoul, Korea – sequence: 4 givenname: Dae-Hyeong orcidid: 0000-0002-4722-1893 surname: Kim fullname: Kim, Dae-Hyeong organization: Center for Nanoparticle Research, Institute for Basic Science (IBS), Seoul, Korea., School of Chemical and Biological Engineering, Institute of Chemical Processes, Seoul National University, Seoul, Korea., Department of Materials Science and Engineering, College of Engineering, Seoul National University, Seoul, Korea |
| BackLink | https://www.kci.go.kr/kciportal/ci/sereArticleSearch/ciSereArtiView.kci?sereArticleSearchBean.artiId=ART002863747$$DAccess content in National Research Foundation of Korea (NRF) |
| BookMark | eNqFkM1r3DAQxUVJaT7PvfoYCrsZSbZlXQIhaZPAQqHZu5Dl0VaNbG0lOWX_-9rZ0NIc0tMMzO-9mXnH5GAIAxLykcKSlkLSizbHvGTA2BKAinfkiLGmWbCS8oM_PVSH5CylHzAhrKqEEB_IIa8kk5SyIyJXwWhf3MRxU9ygd08Yd8VDjjrjxmEqbIjFrXeh9Trl0OtiHVHnHod8St5b7ROevdQTsv7yeX19t1h9vb2_vlotDGdMLCxYJmpNO9oghwoBOg3MSM6NsbqUJa8FUixFyym2jNZN17XcUtHW1laWn5BPe9shWvVonAraPddNUI9RXX1b3ysKwGTTiAmGPTwOW737pb1X2-h6HXcTo55DU3Noag5NzaFNksu9ZDu2PXZm-izqv7J527-TwX2fdj8pyStOa5gMzl8MYvg5Ysqqd8mg93rAMCbFaikFNCXwCa32qIkhpYhWGZd1dmF2dv6NGy9e6f731W_KMqVc |
| CitedBy_id | crossref_primary_10_3390_ph17030300 crossref_primary_10_3390_cells13040363 crossref_primary_10_1002_smll_202303073 crossref_primary_10_3390_gels10100640 crossref_primary_10_1002_anbr_202400126 crossref_primary_10_1186_s12916_024_03775_4 crossref_primary_10_25259_SNI_588_2024 crossref_primary_10_3390_futurepharmacol5010007 crossref_primary_10_2147_IJN_S450853 crossref_primary_10_1021_acs_chemrev_3c00548 crossref_primary_10_1021_acsnano_3c03409 crossref_primary_10_1007_s12033_024_01287_3 crossref_primary_10_1016_j_addr_2023_114853 crossref_primary_10_1002_adhm_202303563 crossref_primary_10_15283_ijsc23062 crossref_primary_10_1016_j_ijbiomac_2025_140025 crossref_primary_10_1021_acs_biomac_3c00846 crossref_primary_10_1007_s11060_024_04763_7 |
| Cites_doi | 10.1002/adhm.201801660 10.1021/acsnano.6b05070 10.1016/j.biomaterials.2009.01.003 10.1021/acs.chemrev.1c00531 10.3390/pharmaceutics14020254 10.3390/ijms222313160 10.1038/srep43271 10.1016/j.jconrel.2017.08.019 10.2147/PPA.S93020 10.1038/s41467-019-13198-y 10.1016/j.jocn.2009.09.004 10.1038/nnano.2017.54 10.1016/j.jconrel.2018.05.008 10.18632/oncotarget.8837 10.1038/s41582-022-00621-0 10.1146/annurev-chembioeng-101420-024336 10.1038/nmat3878 10.1016/j.jconrel.2017.03.007 10.1016/j.jconrel.2020.09.002 10.1126/scitranslmed.aag2942 10.1073/pnas.97.12.6242 10.1021/nn503735w 10.4329/wjr.v3.i11.266 10.1039/D0NR01456G 10.1038/s41467-019-09853-z 10.1016/j.jinf.2013.12.002 10.1038/natrevmats.2016.14 10.1002/adma.202100425 10.1038/s41467-021-21117-3 10.1038/s41565-020-00843-7 10.1016/j.copbio.2021.07.027 10.1016/j.biomaterials.2020.119793 10.1016/S1470-2045(18)30665-X 10.1038/nrn1824 10.1038/s41467-019-14036-x 10.1021/acsnano.8b06201 10.1056/NEJMcibr1309402 10.1038/nrd1414 10.1002/adhm.202100614 10.1016/j.matt.2020.10.020 10.3390/ma11050779 10.3389/fonc.2018.00419 10.1038/s41565-021-00879-3 10.1016/j.ijpharm.2019.01.042 10.1093/neuonc/5.2.79 10.1016/j.jconrel.2018.05.005 10.1038/srep19077 10.1126/sciadv.abd4639 10.1038/s41551-021-00728-7 10.1021/acsmaterialslett.1c00438 10.1038/s41598-019-54283-y 10.1021/nn504210g 10.1021/acsnano.1c07649 10.1615/CritRevOncog.2014011455 |
| ContentType | Journal Article |
| Copyright | Copyright © 2022 The Korean Brain Tumor Society, The Korean Society for Neuro-Oncology, and The Korean Society for Pediatric Neuro-Oncology. Copyright © 2022 The Korean Brain Tumor Society, The Korean Society for Neuro-Oncology, and The Korean Society for Pediatric Neuro-Oncology 2022 The Korean Brain Tumor Society, The Korean Society for Neuro-Oncology, and The Korean Society for Pediatric Neuro-Oncology |
| Copyright_xml | – notice: Copyright © 2022 The Korean Brain Tumor Society, The Korean Society for Neuro-Oncology, and The Korean Society for Pediatric Neuro-Oncology. – notice: Copyright © 2022 The Korean Brain Tumor Society, The Korean Society for Neuro-Oncology, and The Korean Society for Pediatric Neuro-Oncology 2022 The Korean Brain Tumor Society, The Korean Society for Neuro-Oncology, and The Korean Society for Pediatric Neuro-Oncology |
| DBID | AAYXX CITATION 7X8 5PM ADTOC UNPAY ACYCR |
| DOI | 10.14791/btrt.2022.0017 |
| DatabaseName | CrossRef MEDLINE - Academic PubMed Central (Full Participant titles) Unpaywall for CDI: Periodical Content Unpaywall Korean Citation Index |
| DatabaseTitle | CrossRef MEDLINE - Academic |
| DatabaseTitleList | MEDLINE - Academic |
| Database_xml | – sequence: 1 dbid: UNPAY name: Unpaywall url: https://proxy.k.utb.cz/login?url=https://unpaywall.org/ sourceTypes: Open Access Repository |
| DeliveryMethod | fulltext_linktorsrc |
| EISSN | 2288-2413 |
| EndPage | 157 |
| ExternalDocumentID | oai_kci_go_kr_ARTI_10029887 oai:pubmedcentral.nih.gov:9353160 PMC9353160 10_14791_btrt_2022_0017 |
| GrantInformation_xml | – fundername: ; grantid: IBS-R006-A1 |
| GroupedDBID | 5-W 8JR 8XY AAYXX ADBBV ADRAZ ALMA_UNASSIGNED_HOLDINGS AOIJS BAWUL CITATION DIK GX1 HYE HZB KQ8 M48 OK1 PGMZT RPM 7X8 5PM ADTOC UNPAY ACYCR |
| ID | FETCH-LOGICAL-c3227-f0f276a1d18e305e00da02c933ccfa494367e1e47b31eb2168ddb3f17b6ff5f3 |
| IEDL.DBID | M48 |
| ISSN | 2288-2405 2288-2413 |
| IngestDate | Tue Nov 21 21:26:23 EST 2023 Sun Oct 26 04:04:48 EDT 2025 Thu Aug 21 18:15:43 EDT 2025 Thu Jul 10 21:35:04 EDT 2025 Tue Jul 01 03:55:19 EDT 2025 Thu Apr 24 23:12:00 EDT 2025 |
| IsDoiOpenAccess | true |
| IsOpenAccess | true |
| IsPeerReviewed | false |
| IsScholarly | true |
| Issue | 3 |
| Language | English |
| License | This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (https://creativecommons.org/licenses/by-nc/4.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited. other-oa |
| LinkModel | DirectLink |
| MergedId | FETCHMERGED-LOGICAL-c3227-f0f276a1d18e305e00da02c933ccfa494367e1e47b31eb2168ddb3f17b6ff5f3 |
| Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 ObjectType-Review-3 content type line 23 https://doi.org/10.14791/btrt.2022.0017 |
| ORCID | 0000-0002-0412-2270 0000-0002-4722-1893 0000-0002-4771-3396 0000-0002-3797-8024 |
| OpenAccessLink | http://journals.scholarsportal.info/openUrl.xqy?doi=10.14791/btrt.2022.0017 |
| PMID | 35929112 |
| PQID | 2699708403 |
| PQPubID | 23479 |
| PageCount | 7 |
| ParticipantIDs | nrf_kci_oai_kci_go_kr_ARTI_10029887 unpaywall_primary_10_14791_btrt_2022_0017 pubmedcentral_primary_oai_pubmedcentral_nih_gov_9353160 proquest_miscellaneous_2699708403 crossref_citationtrail_10_14791_btrt_2022_0017 crossref_primary_10_14791_btrt_2022_0017 |
| ProviderPackageCode | CITATION AAYXX |
| PublicationCentury | 2000 |
| PublicationDate | 20220701 |
| PublicationDateYYYYMMDD | 2022-07-01 |
| PublicationDate_xml | – month: 7 year: 2022 text: 20220701 day: 1 |
| PublicationDecade | 2020 |
| PublicationTitle | Brain tumor research and treatment |
| PublicationYear | 2022 |
| Publisher | The Korean Brain Tumor Society; The Korean Society for Neuro-Oncology; The Korean Society for Pediatric Neuro-Oncology 대한뇌종양학회 |
| Publisher_xml | – name: The Korean Brain Tumor Society; The Korean Society for Neuro-Oncology; The Korean Society for Pediatric Neuro-Oncology – name: 대한뇌종양학회 |
| References | Mathios (10.14791/btrt.2022.0017_ref35) 2016; 8 Alli (10.14791/btrt.2022.0017_ref16) 2018; 281 Jain (10.14791/btrt.2022.0017_ref18) 2018; 8 Meng (10.14791/btrt.2022.0017_ref50) 2020; 11 Shi (10.14791/btrt.2022.0017_ref52) 2016; 6 van Solinge (10.14791/btrt.2022.0017_ref25) 2022; 18 Cha (10.14791/btrt.2022.0017_ref53) 2022; 16 Lee (10.14791/btrt.2022.0017_ref58) 2019; 10 Westphal (10.14791/btrt.2022.0017_ref41) 2003; 5 Lau (10.14791/btrt.2022.0017_ref43) 2012; 4 Bastiancich (10.14791/btrt.2022.0017_ref51) 2017; 264 Kleinberg (10.14791/btrt.2022.0017_ref42) 2016; 10 Kim (10.14791/btrt.2022.0017_ref20) 2016; 7 Sunwoo (10.14791/btrt.2022.0017_ref33) 2021; 12 Ibrahim (10.14791/btrt.2022.0017_ref40) 2022; 14 Dirkse (10.14791/btrt.2022.0017_ref8) 2019; 10 Koo (10.14791/btrt.2022.0017_ref31) 2020; 5 Joo (10.14791/btrt.2022.0017_ref28) 2021; 7 Nam (10.14791/btrt.2022.0017_ref17) 2018; 11 Jain (10.14791/btrt.2022.0017_ref55) 2014; 13 Cha (10.14791/btrt.2022.0017_ref10) 2020; 328 Nance (10.14791/btrt.2022.0017_ref19) 2014; 8 Komotar (10.14791/btrt.2022.0017_ref5) 2008; 2 Ruan (10.14791/btrt.2022.0017_ref13) 2016; 10 Lesniak (10.14791/btrt.2022.0017_ref34) 2004; 3 Xue (10.14791/btrt.2022.0017_ref11) 2017; 12 Han (10.14791/btrt.2022.0017_ref23) 2019; 9 Jung (10.14791/btrt.2022.0017_ref7) 2021; 12 Wang (10.14791/btrt.2022.0017_ref37) 2021; 5 Pena (10.14791/btrt.2022.0017_ref38) 2021; 22 Bastiancich (10.14791/btrt.2022.0017_ref46) 2019; 559 Tran (10.14791/btrt.2022.0017_ref2) 2010; 17 Cha (10.14791/btrt.2022.0017_ref56) 2019; 8 Magill (10.14791/btrt.2022.0017_ref44) 2020; 12 Holland (10.14791/btrt.2022.0017_ref3) 2000; 97 Lee (10.14791/btrt.2022.0017_ref26) 2021; 72 Ganipineni (10.14791/btrt.2022.0017_ref6) 2018; 281 Wen (10.14791/btrt.2022.0017_ref15) 2020; 237 Wilhelm (10.14791/btrt.2022.0017_ref12) 2016; 1 Colen (10.14791/btrt.2022.0017_ref24) 2011; 3 Koo (10.14791/btrt.2022.0017_ref29) 2021; 3 Lee (10.14791/btrt.2022.0017_ref57) 2021; 33 Di Mascolo (10.14791/btrt.2022.0017_ref49) 2021; 16 Yoo (10.14791/btrt.2022.0017_ref32) 2021; 10 Shen (10.14791/btrt.2022.0017_ref14) 2018; 12 Abbott (10.14791/btrt.2022.0017_ref9) 2006; 7 Das (10.14791/btrt.2022.0017_ref1) 2018; 19 Zhang (10.14791/btrt.2022.0017_ref21) 2017; 263 Engelberth (10.14791/btrt.2022.0017_ref39) 2014; 19 Ramachandran (10.14791/btrt.2022.0017_ref48) 2017; 7 Szvalb (10.14791/btrt.2022.0017_ref45) 2014; 68 Cho (10.14791/btrt.2022.0017_ref30) 2022; 122 Zhang (10.14791/btrt.2022.0017_ref47) 2021; 16 Sunwoo (10.14791/btrt.2022.0017_ref27) 2020; 3 Cha (10.14791/btrt.2022.0017_ref54) 2020; 12 Das (10.14791/btrt.2022.0017_ref4) 2013; 369 Stephen (10.14791/btrt.2022.0017_ref22) 2014; 8 Allard (10.14791/btrt.2022.0017_ref36) 2009; 30 |
| References_xml | – volume: 8 start-page: 1801660 year: 2019 ident: 10.14791/btrt.2022.0017_ref56 publication-title: Adv Healthc Mater doi: 10.1002/adhm.201801660 – volume: 10 start-page: 10086 year: 2016 ident: 10.14791/btrt.2022.0017_ref13 publication-title: ACS Nano doi: 10.1021/acsnano.6b05070 – volume: 30 start-page: 2302 year: 2009 ident: 10.14791/btrt.2022.0017_ref36 publication-title: Biomaterials doi: 10.1016/j.biomaterials.2009.01.003 – volume: 122 start-page: 5068 year: 2022 ident: 10.14791/btrt.2022.0017_ref30 publication-title: Chem Rev doi: 10.1021/acs.chemrev.1c00531 – volume: 14 start-page: 254 year: 2022 ident: 10.14791/btrt.2022.0017_ref40 publication-title: Pharmaceutics doi: 10.3390/pharmaceutics14020254 – volume: 22 start-page: 13160 year: 2021 ident: 10.14791/btrt.2022.0017_ref38 publication-title: Int J Mol Sci doi: 10.3390/ijms222313160 – volume: 7 start-page: 43271 year: 2017 ident: 10.14791/btrt.2022.0017_ref48 publication-title: Sci Rep doi: 10.1038/srep43271 – volume: 264 start-page: 45 year: 2017 ident: 10.14791/btrt.2022.0017_ref51 publication-title: J Control Release doi: 10.1016/j.jconrel.2017.08.019 – volume: 10 start-page: 2397 year: 2016 ident: 10.14791/btrt.2022.0017_ref42 publication-title: Patient Prefer Adherence doi: 10.2147/PPA.S93020 – volume: 10 start-page: 5205 year: 2019 ident: 10.14791/btrt.2022.0017_ref58 publication-title: Nat Commun doi: 10.1038/s41467-019-13198-y – volume: 17 start-page: 417 year: 2010 ident: 10.14791/btrt.2022.0017_ref2 publication-title: J Clin Neurosci doi: 10.1016/j.jocn.2009.09.004 – volume: 12 start-page: 692 year: 2017 ident: 10.14791/btrt.2022.0017_ref11 publication-title: Nat Nanotechnol doi: 10.1038/nnano.2017.54 – volume: 281 start-page: 42 year: 2018 ident: 10.14791/btrt.2022.0017_ref6 publication-title: J Control Release doi: 10.1016/j.jconrel.2018.05.008 – volume: 7 start-page: 29400 year: 2016 ident: 10.14791/btrt.2022.0017_ref20 publication-title: Oncotarget doi: 10.18632/oncotarget.8837 – volume: 5 start-page: 202000407 year: 2020 ident: 10.14791/btrt.2022.0017_ref31 publication-title: Adv Mater Technol – volume: 2 start-page: 421 year: 2008 ident: 10.14791/btrt.2022.0017_ref5 publication-title: Clin Med Oncol – volume: 18 start-page: 221 year: 2022 ident: 10.14791/btrt.2022.0017_ref25 publication-title: Nat Rev Neurol doi: 10.1038/s41582-022-00621-0 – volume: 12 start-page: 359 year: 2021 ident: 10.14791/btrt.2022.0017_ref33 publication-title: Annu Rev Chem Biomol Eng doi: 10.1146/annurev-chembioeng-101420-024336 – volume: 13 start-page: 308 year: 2014 ident: 10.14791/btrt.2022.0017_ref55 publication-title: Nat Mater doi: 10.1038/nmat3878 – volume: 263 start-page: 112 year: 2017 ident: 10.14791/btrt.2022.0017_ref21 publication-title: J Control Release doi: 10.1016/j.jconrel.2017.03.007 – volume: 328 start-page: 350 year: 2020 ident: 10.14791/btrt.2022.0017_ref10 publication-title: J Control Release doi: 10.1016/j.jconrel.2020.09.002 – volume: 8 start-page: 370ra180 year: 2016 ident: 10.14791/btrt.2022.0017_ref35 publication-title: Sci Transl Med doi: 10.1126/scitranslmed.aag2942 – volume: 97 start-page: 6242 year: 2000 ident: 10.14791/btrt.2022.0017_ref3 publication-title: Proc Natl Acad Sci U S A doi: 10.1073/pnas.97.12.6242 – volume: 8 start-page: 10383 year: 2014 ident: 10.14791/btrt.2022.0017_ref22 publication-title: ACS Nano doi: 10.1021/nn503735w – volume: 3 start-page: 266 year: 2011 ident: 10.14791/btrt.2022.0017_ref24 publication-title: World J Radiol doi: 10.4329/wjr.v3.i11.266 – volume: 12 start-page: 10456 year: 2020 ident: 10.14791/btrt.2022.0017_ref54 publication-title: Nanoscale doi: 10.1039/D0NR01456G – volume: 10 start-page: 1787 year: 2019 ident: 10.14791/btrt.2022.0017_ref8 publication-title: Nat Commun doi: 10.1038/s41467-019-09853-z – volume: 68 start-page: 216 year: 2014 ident: 10.14791/btrt.2022.0017_ref45 publication-title: J Infect doi: 10.1016/j.jinf.2013.12.002 – volume: 1 start-page: 16014 year: 2016 ident: 10.14791/btrt.2022.0017_ref12 publication-title: Nat Rev Mater doi: 10.1038/natrevmats.2016.14 – volume: 33 start-page: 2100425 year: 2021 ident: 10.14791/btrt.2022.0017_ref57 publication-title: Adv Mater doi: 10.1002/adma.202100425 – volume: 12 start-page: 1014 year: 2021 ident: 10.14791/btrt.2022.0017_ref7 publication-title: Nat Commun doi: 10.1038/s41467-021-21117-3 – volume: 16 start-page: 538 year: 2021 ident: 10.14791/btrt.2022.0017_ref47 publication-title: Nat Nanotechnol doi: 10.1038/s41565-020-00843-7 – volume: 72 start-page: 13 year: 2021 ident: 10.14791/btrt.2022.0017_ref26 publication-title: Curr Opin Biotechnol doi: 10.1016/j.copbio.2021.07.027 – volume: 237 start-page: 119793 year: 2020 ident: 10.14791/btrt.2022.0017_ref15 publication-title: Biomaterials doi: 10.1016/j.biomaterials.2020.119793 – volume: 19 start-page: e514 year: 2018 ident: 10.14791/btrt.2022.0017_ref1 publication-title: Lancet Oncol doi: 10.1016/S1470-2045(18)30665-X – volume: 7 start-page: 41 year: 2006 ident: 10.14791/btrt.2022.0017_ref9 publication-title: Nat Rev Neurosci doi: 10.1038/nrn1824 – volume: 11 start-page: 594 year: 2020 ident: 10.14791/btrt.2022.0017_ref50 publication-title: Nat Commun doi: 10.1038/s41467-019-14036-x – volume: 12 start-page: 11355 year: 2018 ident: 10.14791/btrt.2022.0017_ref14 publication-title: ACS Nano doi: 10.1021/acsnano.8b06201 – volume: 369 start-page: 1561 year: 2013 ident: 10.14791/btrt.2022.0017_ref4 publication-title: N Engl J Med doi: 10.1056/NEJMcibr1309402 – volume: 3 start-page: 499 year: 2004 ident: 10.14791/btrt.2022.0017_ref34 publication-title: Nat Rev Drug Discov doi: 10.1038/nrd1414 – volume: 10 start-page: 2100614 year: 2021 ident: 10.14791/btrt.2022.0017_ref32 publication-title: Adv Healthc Mater doi: 10.1002/adhm.202100614 – volume: 3 start-page: 1923 year: 2020 ident: 10.14791/btrt.2022.0017_ref27 publication-title: Matter doi: 10.1016/j.matt.2020.10.020 – volume: 11 start-page: 779 year: 2018 ident: 10.14791/btrt.2022.0017_ref17 publication-title: Materials (Basel) doi: 10.3390/ma11050779 – volume: 8 start-page: 419 year: 2018 ident: 10.14791/btrt.2022.0017_ref18 publication-title: Front Oncol doi: 10.3389/fonc.2018.00419 – volume: 16 start-page: 820 year: 2021 ident: 10.14791/btrt.2022.0017_ref49 publication-title: Nat Nanotechnol doi: 10.1038/s41565-021-00879-3 – volume: 559 start-page: 220 year: 2019 ident: 10.14791/btrt.2022.0017_ref46 publication-title: Int J Pharm doi: 10.1016/j.ijpharm.2019.01.042 – volume: 5 start-page: 79 year: 2003 ident: 10.14791/btrt.2022.0017_ref41 publication-title: Neuro Oncol doi: 10.1093/neuonc/5.2.79 – volume: 281 start-page: 29 year: 2018 ident: 10.14791/btrt.2022.0017_ref16 publication-title: J Control Release doi: 10.1016/j.jconrel.2018.05.005 – volume: 6 start-page: 19077 year: 2016 ident: 10.14791/btrt.2022.0017_ref52 publication-title: Sci Rep doi: 10.1038/srep19077 – volume: 7 start-page: eabd4639 year: 2021 ident: 10.14791/btrt.2022.0017_ref28 publication-title: Sci Adv doi: 10.1126/sciadv.abd4639 – volume: 5 start-page: 1048 year: 2021 ident: 10.14791/btrt.2022.0017_ref37 publication-title: Nat Biomed Eng doi: 10.1038/s41551-021-00728-7 – volume: 3 start-page: 1528 year: 2021 ident: 10.14791/btrt.2022.0017_ref29 publication-title: ACS Mater Lett doi: 10.1021/acsmaterialslett.1c00438 – volume: 9 start-page: 17936 year: 2019 ident: 10.14791/btrt.2022.0017_ref23 publication-title: Sci Rep doi: 10.1038/s41598-019-54283-y – volume: 8 start-page: 10655 year: 2014 ident: 10.14791/btrt.2022.0017_ref19 publication-title: ACS Nano doi: 10.1021/nn504210g – volume: 4 start-page: e66 year: 2012 ident: 10.14791/btrt.2022.0017_ref43 publication-title: Cureus – volume: 16 start-page: 554 year: 2022 ident: 10.14791/btrt.2022.0017_ref53 publication-title: ACS Nano doi: 10.1021/acsnano.1c07649 – volume: 19 start-page: 281 year: 2014 ident: 10.14791/btrt.2022.0017_ref39 publication-title: Crit Rev Oncog doi: 10.1615/CritRevOncog.2014011455 – volume: 12 start-page: e7731 year: 2020 ident: 10.14791/btrt.2022.0017_ref44 publication-title: Cureus |
| SSID | ssj0001255777 |
| Score | 2.3099906 |
| SecondaryResourceType | review_article |
| Snippet | Glioblastoma multiforme (GBM) is a brain tumor notorious for its malignancy. The key reason for the limited efficacy of standard treatment is the high... Glioblastoma multiforme (GBM) is a brain tumor notorious for its malignancy. The key reason for the lim- ited efficacy of standard treatment is the high... |
| SourceID | nrf unpaywall pubmedcentral proquest crossref |
| SourceType | Open Website Open Access Repository Aggregation Database Enrichment Source Index Database |
| StartPage | 151 |
| SubjectTerms | Review 신경외과학 |
| SummonAdditionalLinks | – databaseName: Unpaywall dbid: UNPAY link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlV1Nb9QwFHwq2wNc-BAgwpeC4ACHZOM4sdfHilIKggqhrVROlu3Y7WqzySpNhMqvxy-bLGwlhHqKpTiJk7HjefJ4HsAbazwr4E5F6P8UZUr7MdcvOCpP7tnMckVxc_LXE3Z8mn0-y8_2gIx7YXrRvtGLuCpXcbW46LWV65WZjjqxqaC-2zAfpe-z3NPvCeyfnnw7-IFJ5FJEPetli0OZ0MHOJ-OCTHXboHwyRY_OPkPZn5noVtW4HZJ5XSJ5u6vW6uqnKsu_5p-je_B9bPlGdrKMu1bH5tc1U8cbvdp9uDuw0fBgc-oB7NnqIYgvOL-Fh013Hh7aEoUbV-HoYmsvQ09zw4_lotaeeLf1SoXzUaz-COZHH-bvj6Mhw0Jk_EDmkUtcypkiBZlZP_BtkhQqSY2g1BinMpFRxi2xGdeU-BCcsFlRaOoI18y53NHHMKnqyj6BUKjcJIqZIs_TjHOn6cwQbjIjdC7SRAcQjx9bmsF9HJNglBKjEERHIjoS0UGdHQ_g7faC9cZ4499VX3v05NIsJJpl4_G8lstG-pDgE5oyp8L_SgN4NaIr_RDCdRFV2bq7lCkTgic-0qUB8B3Yt0_G--6e8QD2ZtwDZgG823aQ_7X36Q3qPoM7WN4IhJ_DpG06-8LToFa_HDr-b0TKBqA priority: 102 providerName: Unpaywall |
| Title | Local Drug Delivery Strategies for Glioblastoma Treatment |
| URI | https://www.proquest.com/docview/2699708403 https://pubmed.ncbi.nlm.nih.gov/PMC9353160 https://www.ncbi.nlm.nih.gov/pmc/articles/9353160 https://www.kci.go.kr/kciportal/ci/sereArticleSearch/ciSereArtiView.kci?sereArticleSearchBean.artiId=ART002863747 |
| UnpaywallVersion | submittedVersion |
| Volume | 10 |
| hasFullText | 1 |
| inHoldings | 1 |
| isFullTextHit | |
| isPrint | |
| ispartofPNX | Brain Tumor Research and Treatment, 2022, 10(3), , pp.151-157 |
| journalDatabaseRights | – providerCode: PRVAFT databaseName: Open Access Digital Library customDbUrl: eissn: 2288-2413 dateEnd: 99991231 omitProxy: true ssIdentifier: ssj0001255777 issn: 2288-2413 databaseCode: KQ8 dateStart: 20130101 isFulltext: true titleUrlDefault: http://grweb.coalliance.org/oadl/oadl.html providerName: Colorado Alliance of Research Libraries – providerCode: PRVBFR databaseName: Free Medical Journals customDbUrl: eissn: 2288-2413 dateEnd: 99991231 omitProxy: true ssIdentifier: ssj0001255777 issn: 2288-2413 databaseCode: DIK dateStart: 20130101 isFulltext: true titleUrlDefault: http://www.freemedicaljournals.com providerName: Flying Publisher – providerCode: PRVFQY databaseName: GFMER Free Medical Journals customDbUrl: eissn: 2288-2413 dateEnd: 99991231 omitProxy: true ssIdentifier: ssj0001255777 issn: 2288-2413 databaseCode: GX1 dateStart: 0 isFulltext: true titleUrlDefault: http://www.gfmer.ch/Medical_journals/Free_medical.php providerName: Geneva Foundation for Medical Education and Research – providerCode: PRVERR databaseName: [Open Access] KoreaMed customDbUrl: eissn: 2288-2413 dateEnd: 99991231 omitProxy: true ssIdentifier: ssj0001255777 issn: 2288-2413 databaseCode: 5-W dateStart: 20130101 isFulltext: true titleUrlDefault: https://koreamed.org/journals providerName: Korean Association of Medical Journal Editors – providerCode: PRVAQN databaseName: PubMed Central customDbUrl: eissn: 2288-2413 dateEnd: 99991231 omitProxy: true ssIdentifier: ssj0001255777 issn: 2288-2413 databaseCode: RPM dateStart: 20130101 isFulltext: true titleUrlDefault: https://www.ncbi.nlm.nih.gov/pmc/ providerName: National Library of Medicine – providerCode: PRVFZP databaseName: Scholars Portal Journals: Open Access customDbUrl: eissn: 2288-2413 dateEnd: 20250131 omitProxy: true ssIdentifier: ssj0001255777 issn: 2288-2413 databaseCode: M48 dateStart: 20130401 isFulltext: true titleUrlDefault: http://journals.scholarsportal.info providerName: Scholars Portal |
| link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Bb9MwFH5imwS7IBAgAqMKggMcMuI4sesDQhNjDMQmDq00Tpbt2KNaSLa0FfTf816aFoqGkDjlkMSOPvv5fc9--R7Ac--QFchgEtJ_SnJj0ea6A0eD5F4MvTScfk4-ORXH4_zjWXH2qxxQD-D02tCO6kmN22r_x9XiDRr8azL4XCr2ys5aSovMSHuTyS3YQTelqI7DSc_1lxsuRSG7SoxZRrMDmUov9XNNG7twkxfIHBjLNhzWVt2GDS76ZyblrXl9aRbfTVX95qaO7sDtnl_GB8sJcRdu-PoeqE_kseLDdn4eH_qKUjEW8UqX1k9jJK7x-2rSWKTSs-abiUer9PP7MDp6N3p7nPQ1ExKHpimTkIZMCsNKNvRoyj5NS5NmTnHuXDC5yrmQnvlcWs4wqGZiWJaWByatCKEI_AFs103tH0KsTOFSI1xZFFkuZbB86Jh0uVMWkUltBPsrXLTr9cSprEWlKa4gTDVhqglTypyTEbxYv3C5lNL4-6PPEGh94Saa5K_pet7oi1Yjyf9AMsuZwsUxgqergdBoFHTSYWrfzKc6E0rJFGNXHoHcGKF1z9Tu5p168rWT11Yc1yWRRvByPZb_-t5H_93LY9ilVpYJwHuwPWvn_gnSnJkddNN30O0_DWBnfPr54MtP6TL9gw |
| linkProvider | Scholars Portal |
| linkToUnpaywall | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlV1Nb9QwFHwq2wNc-BAgwpeC4ACHZOM4sdfHilIKggqhrVROlu3Y7WqzySpNhMqvxy-bLGwlhHqKpTiJk7HjefJ4HsAbazwr4E5F6P8UZUr7MdcvOCpP7tnMckVxc_LXE3Z8mn0-y8_2gIx7YXrRvtGLuCpXcbW46LWV65WZjjqxqaC-2zAfpe-z3NPvCeyfnnw7-IFJ5FJEPetli0OZ0MHOJ-OCTHXboHwyRY_OPkPZn5noVtW4HZJ5XSJ5u6vW6uqnKsu_5p-je_B9bPlGdrKMu1bH5tc1U8cbvdp9uDuw0fBgc-oB7NnqIYgvOL-Fh013Hh7aEoUbV-HoYmsvQ09zw4_lotaeeLf1SoXzUaz-COZHH-bvj6Mhw0Jk_EDmkUtcypkiBZlZP_BtkhQqSY2g1BinMpFRxi2xGdeU-BCcsFlRaOoI18y53NHHMKnqyj6BUKjcJIqZIs_TjHOn6cwQbjIjdC7SRAcQjx9bmsF9HJNglBKjEERHIjoS0UGdHQ_g7faC9cZ4499VX3v05NIsJJpl4_G8lstG-pDgE5oyp8L_SgN4NaIr_RDCdRFV2bq7lCkTgic-0qUB8B3Yt0_G--6e8QD2ZtwDZgG823aQ_7X36Q3qPoM7WN4IhJ_DpG06-8LToFa_HDr-b0TKBqA |
| openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Local+Drug+Delivery+Strategies+for+Glioblastoma+Treatment&rft.jtitle=Brain+tumor+research+and+treatment&rft.au=Cha%2C+Gi+Doo&rft.au=Jung%2C+Sonwoo&rft.au=Choi%2C+Seung+Hong&rft.au=Kim%2C+Dae-Hyeong&rft.date=2022-07-01&rft.pub=The+Korean+Brain+Tumor+Society%3B+The+Korean+Society+for+Neuro-Oncology%3B+The+Korean+Society+for+Pediatric+Neuro-Oncology&rft.issn=2288-2405&rft.eissn=2288-2413&rft.volume=10&rft.issue=3&rft.spage=151&rft.epage=157&rft_id=info:doi/10.14791%2Fbtrt.2022.0017&rft_id=info%3Apmid%2F35929112&rft.externalDocID=PMC9353160 |
| thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=2288-2405&client=summon |
| thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=2288-2405&client=summon |
| thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=2288-2405&client=summon |